Liquid Biopsy for Detection of Driver Mutation in NSCLC
NCT02778854 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2018-03-08
Summary
The purpose of this study is to evaluate the diagnostic and prognostic efficacy of liquid biopsy in different specimens and in different methods compared with tissue detection .
Conditions
- Non Small Cell Lung Cancer
Interventions
- GENETIC
-
detection of driver mutation
participants are received gene detection via the liquid biopsy
Sponsors & Collaborators
-
Chinese PLA General Hospital
lead OTHER
Principal Investigators
-
Liang-an Chen, MD,PHD · Chinese PLA General Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2018-12-31
- Completion
- 2020-11-30
Countries
- China
Study Locations
More Related Trials
-
Novel Detection System for Lung Cancer Curative Effect Monitoring
NCT02666755 ·Status: UNKNOWN
-
Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients
NCT04229121 ·Status: UNKNOWN
-
An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.
NCT07182214 ·Status: RECRUITING
-
Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer
NCT02941003 ·Status: UNKNOWN ·Phase: NA
-
Liquid Biopsy for Early Non-small Lung Cancer Detection
NCT05462795 ·Status: COMPLETED
-
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
NCT06443684 ·Status: RECRUITING
-
The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC
NCT06287593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
NCT04156360 ·Status: UNKNOWN
-
Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment
NCT00752076 ·Status: UNKNOWN ·Phase: NA
-
Molecular Diagnosis of Lung Cancer Via Bronchoscopy: The Significance of Bronchial Liquid Biopsy (ctDNA and ctRNA)
NCT06228508 ·Status: NOT_YET_RECRUITING
-
ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction Chemoimmunotherapy
NCT05822284 ·Status: NOT_YET_RECRUITING
-
NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy
NCT04636047 ·Status: UNKNOWN
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
Monitoring the Changes of Tumor-related Biomarkers Before and After Pulmonary Nodule Biopsy.
NCT03397355 ·Status: UNKNOWN
-
Detection of Genetic Markers of Lung Cancer
NCT00280202 ·Status: RECRUITING
-
A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer
NCT04951154 ·Status: COMPLETED
-
Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China
NCT01928836 ·Status: COMPLETED
-
cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China
NCT02980536 ·Status: UNKNOWN
-
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
NCT06198868 ·Status: RECRUITING
-
Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer
NCT04266691 ·Status: COMPLETED
-
Gene Mutations in Non-Small Cell Lung Cancer Cells
NCT00977509 ·Status: UNKNOWN
-
Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.
NCT03220230 ·Status: COMPLETED
-
A Study to Explore Treatment Regimens and Clinical Outcomes of the NSCLC Patients With Different Dirver Genes
NCT03710629 ·Status: UNKNOWN
-
Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
NCT01141686 ·Status: COMPLETED
-
Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC
NCT07186855 ·Status: COMPLETED